Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

Lignende værker

• Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)
  af: Witjes, J Alfred, et al.
  Udgivet: (2013)
• Defining and Treating the Spectrum of Intermediate-Risk NMIBC
  af: Kamat, Ashish M., et al.
  Udgivet: (2014)
• Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
  af: Roumiguié, Mathieu, et al.
  Udgivet: (2020)
• Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-Muscle Invasive Bladder Cancer
  af: Tabayoyong, William B., et al.
  Udgivet: (2018)
• Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
  af: Li, Roger, et al.
  Udgivet: (2017)